Advertisement
Video case report| Volume 6, ISSUE 2, P80-83, February 2021

Download started.

Ok

Bilateral balloon expandable biodegradable stent (Y-stent) for postcholecystectomy perihilar biliary stricture

Open AccessPublished:January 07, 2021DOI:https://doi.org/10.1016/j.vgie.2020.11.001

      Abbreviations:

      BEBS (balloon expandable biodegradable stent), RHD (right hepatic duct), FCSEMS (fully covered self-expandable metal stent)
      A 26-year-old woman had a complicated laparoscopic cholecystectomy 12 months earlier that led to biliary stricture (Fig. 1). She required multiple ERCP sessions with balloon dilation and incremental plastic stents over the past year, without resolution of biliary stricture.
      Figure thumbnail gr1
      Figure 1Initial cholangiagram performed 12 months after cholecystectomy showing perihilar stricture.
      At ERCP (using an EVS JF 180; Olympus, Tokyo, Japan), blocked biliary plastic stents were removed using a snare (Video 1, available online at www.giejournal.org). On cholangiogram, Multiple soft stones seen on cholangiogram were cleared with balloon sweep. The perihilar stricture (involving the common hepatic duct and bifurcation of both the right and left hepatic ducts) was persistent, with an overlying surgical clip (Fig. 2).
      Figure thumbnail gr2
      Figure 2Present cholangiogram showing persistent perihilar stricture involving the common hepatic duct and bifurcation of both right and left hepatic ducts, with overlying surgical clips.
      A novel biliary balloon expandable biodegradable stent (BEBS) (UNITY-B; AMG International, Winsen, Germany) was considered for the persistent perihilar benign biliary stricture. The BEBS is a radiolucent stent tightly crimped over a deflated balloon (Figs. 3 and 4). This stent is currently not approved by the U.S. Food and Drug Administration.
      Figure thumbnail gr3
      Figure 3Novel biliary balloon expandable biodegradable stent tightly crimped over a deflated balloon.
      Figure thumbnail gr4
      Figure 4A, Balloon Expandable Biodegradable Stent (BEBS) assembly over the guidewire attached to a pressure gauge measurement device. B, Balloon and stent expansion starts from the proximal end of the balloon inflation. C, Fully expanded BEBS and balloon at the recommended pressure. D, Deflated balloon with BEBS remaining fully expanded.
      Two 0.025-inch guidewires (Visiglide, Olympus America, Center Valley, Penn) were passed into the left and right hepatic ducts. After accurate positioning of the stent assembly was confirmed using the radio-opaque markers at both ends, the underlying balloon was inflated with contrast. This was followed by placement of a 10-mm caliber (57-mm-long) BEBS across the approved left hepatic duct stricture after dilation of the balloon. The BEBS is radiolucent except for 2 radio-opaque markers each at both ends (Fig. 5). Another guidewire was negotiated through the mesh of the biodegradable stent using the prior right hepatic duct (RHD) wire for proper direction (Fig. 6). The latter was removed after successful passage of through-the-stent wire. The RHD stricture was dilated with a standard balloon (8 mm, Titan, Cook Medical LLC, Bloomington, Ind, USA). This was followed by similar placement of an 8-mm caliber BEBS (57 mm length) through the mesh of the biodegradable stent placed in the left hepatic duct (in a stent-in-stent “Y shaped” configuration). Accurate positioning of both BEBSs was confirmed on fluoroscopy showing the end markers and aerobilia (Fig. 7). Mild periprocedural pain was managed with analgesics on an outpatient basis. A CT scan performed 24 hours later confirmed that the bilateral stents were open (Fig. 8). The patient was comfortable at 8 weeks after the procedure and has normal biochemistry (Video 1, available online at www.giejournal.org).
      Figure thumbnail gr5
      Figure 5Biliary balloon expandable biodegradable stent placed across the stricture in the left hepatic duct.
      Figure thumbnail gr6
      Figure 6Guidewire being negotiated through the mesh of the left biodegradable stent, across the right hepatic duct stricture.
      Figure thumbnail gr7
      Figure 7Fluoroscopic image showing upper and lower end of the radiopaque markers of the balloon expandable biodegradable stent, confirming placement of both stents across the stricture.
      Figure thumbnail gr8
      Figure 8CT reconstructed image 24 hours after the procedure.
      Biodegradable stents with different stent designs have been used for various indications (after liver transplant, after Whipple with biliary anastomoses for chronic pancreatitis) to prevent bile leaks or in patients with equivocal common biliary duct clearance.
      • Lakhtakia S.
      • Yaacob N.
      • Jarmin R.
      • et al.
      339 novel bio-degradable stent in patients with biliary or pancreatic obstruction: a pilot study to assess clinical efficacy and safety [abstract].
      ,
      • Repici A.
      • Vleggaar F.P.
      • Hassan C.
      • et al.
      Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study.
      Such biliary stents have efficacy for benign biliary strictures.
      • Siiki A.
      • Rinta-Kiikka I.
      • Sand J.
      • et al.
      A pilot study of endoscopically inserted biodegradable biliary stents in the treatment of benign biliary strictures and cystic duct leaks.
      Benign common biliary duct strictures can be managed efficiently endoscopically by serial placement of multiple plastic stents or a single fully covered self-expandable metal stent (FCSEMS). However, complex benign hilar biliary strictures pose a greater challenge, with options including bilateral multiple plastic stents placed over several ERCP procedures, a combination of plastic on one side and an FCSEMS on the contralateral side, and, rarely, a bilateral FCSEMS.
      • Devière J.
      • Nageshwar Reddy D.
      • Püspök A.
      • et al.
      Successful management of benign biliary strictures with fully covered self-expanding metal stents.
      The advantage of the BEBS is continuous dilation of the stricture with remodeling of the bile duct around the expanded stent without the need for additional procedure(s) to remove or replace the stent. This case report presents the use of the novel biliary BEBS for postcholecystectomy perihilar benign biliary stricture. An additional interesting aspect is that a BEBS can be placed stent-in-stent (Y-shaped-configuration), which may be useful for biliary drainage in complex benign or indeterminate biliary strictures.

      Acknowledgment

      Supported by a Robert W. Summers grant from the American Society for Gastrointestinal Endoscopy.

      Disclosure

      All authors disclosed no financial relationships.

      Supplementary data

      References

        • Lakhtakia S.
        • Yaacob N.
        • Jarmin R.
        • et al.
        339 novel bio-degradable stent in patients with biliary or pancreatic obstruction: a pilot study to assess clinical efficacy and safety [abstract].
        Gastrointest Endosc. 2018; 87: AB71-AB72
        • Repici A.
        • Vleggaar F.P.
        • Hassan C.
        • et al.
        Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study.
        Gastrointest Endosc. 2010; 72: 927-934
        • Siiki A.
        • Rinta-Kiikka I.
        • Sand J.
        • et al.
        A pilot study of endoscopically inserted biodegradable biliary stents in the treatment of benign biliary strictures and cystic duct leaks.
        Gastrointest Endosc. 2018; 87: 1132-1137
        • Devière J.
        • Nageshwar Reddy D.
        • Püspök A.
        • et al.
        Successful management of benign biliary strictures with fully covered self-expanding metal stents.
        Gastroenterology. 2014; 147: 385-395